Efficacy of Direct CAtheterisation of the OMbilical Vein in Emergency Through Wharton's Jelly
ConditionNewborn Morbidity
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorHôpital NOVO
About this trial
The aim of this study is to demonstrate, with a good level of evidence, the efficacy, safety and feasibility of placing an umbilical route through Wharton's jelly, in the context of emergency situations in the delivery room.
Eligibility criteria
Qualifiers
Full-term newborn (≥ 37 SA)
Newborn for whom a resuscitation decision has been taken.
Newborn in circulatory arrest, or in profound bradycardia < 60 bpm, requiring an injection of adrenaline in the delivery room, the indication being established in accordance with the recommendations of the European Resuscitation Council 2021, after completion of the first stages of cardiopulmonary resuscitation, including the establishment of effective ventilation
Newborn beneficiary of a social security scheme or entitled person.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Umbilical vein catheterization through Wharton's jelly procedure
Treatment groups
26 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov